New Discoveries in the Field of Neuropharmacology: 2nd Edition
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 28 February 2027 | Viewed by 294
Editors
Interests: blood brain barrier; drug safety; drug arrhythmogenic effects; neuropharmacology; epileptogenesis; depression
Special Issues, Collections and Topics in MDPI journals
Interests: biophysical and pharmacological properties of ion channels (particularly ENaC/Deg and TRP channels); mathematical modeling of complex biological systems; applied research in cardiac electrophysiology and cardiac safety drug testing; stem cells–diagnostic and therapeutic applications
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This is an inspiring time in biomedical sciences, where new, dynamic methods are being developed and used to produce groundbreaking results in fundamental and applied research, including neuroscience and related fields, such as neuropharmacology. Every year, new promising drugs (new molecular entities) are approved and launched on the market, offering hope to numerous patients affected by severe and debilitating neurologic and psychiatric disorders. This outcome is the result of the systematic application of advanced and highly effective techniques along the different stages of drug R&D pipelines, starting with in silico methods, new in vitro assays, high-throughput screening approaches, animal models of disease, wide genome sequencing and gene expression techniques, powerful transfection vectors, gene editing, stem cells, and many other marvels of modern science. To reflect this extensive progress in neuropharmacology research, we are launching a Special Issue in the prestigious and highly dynamic Biomolecules journal. Therefore, as guest editors, we warmly invite you to contribute by submitting manuscripts containing some of your recent original research results or comprehensive review studies on this topic. We aim to expedite a fair evaluation in this open-access publication of selected papers, offering good scientific visibility.
Yours sincerely,
Dr. Beatrice Mihaela Radu
Dr. Bogdan Amuzescu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurologic and psychiatric diseases pharmacology
- in silico drug screening
- in vitro pharmacology assays
- animal models
- neuropharmacogenomics
- drug safety
- blood brain barrier
- electrophysiology
- patch-clamp
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- New Discoveries in the Field of Neuropharmacology in Biomolecules (6 articles)
